OpenAlex
PricingAboutJobs
Log inGet started
Work

Dapagliflozin: A Novel Sodium‐Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

HTML

Year: 2012
Type: review
Source: Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
DOI: 10.1002/phar.1010
Authors: Niren K. Shah, Wasim E. Deeb, Rushab Choksi, Benjamin J. Epstein
Institutions: Baptist Medical Center Jacksonville, University of Florida Health, University of Florida
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, SGLT2 inhibitors, type 2 diabetes, oral antidiabetic drugs, hyperglycemia, renal glucose reabsorption, insulin secretion, insulin sensitivity, glycemic control, HbA1c, weight loss, blood pressure, hypoglycemia, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2044909864
FWCI: 0.706
Cites: 71
Cited by: 56
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security